Detection and Termination of an Extended Low-frequency Hospital Outbreak of GIM-1-producing Pseudomonas Aeruginosa ST111 in Germany
Overview
Authors
Affiliations
Background: Metallo-β-lactamase German imipenemase-1 (GIM-1)-mediated carbapenem resistance is emerging in Germany but has not spread beyond a very localized region. The aim of this study was to describe the first outbreak of an extensively drug-resistant GIM-1-carrying Pseudomonas aeruginosa strain affecting 29 patients in a tertiary care hospital from 2002-2013.
Methods: The outbreak was studied retrospectively and prospectively by a combination of molecular methods (carbapenemase polymerase chain reaction [PCR]), genotyping (DiversiLab, pulsed field gel electrophoresis and multi-locus sequence typing, bioMérieux, Marcy l'Etoile, France), descriptive epidemiology, and extensive environmental investigations using swabs with liquid transport medium, blaGIM-1 PCR, directly from the medium and culture.
Results: Of the 29 affected patients, 24 had been admitted to a surgical intensive care unit at some point, where environmental sampling revealed a high burden of blaGIM-1 in the wastewater system. The outbreak strain was found in several sinks and on a reusable hair washbasin. Initially, general infection control measures were applied; thereafter, specific measures were implemented, including the restriction of washbasin use. Continued surveillance over a period of 2 years has revealed no further case of GIM-1-carrying Pseudomonas aeruginosa.
Conclusion: This long-term outbreak highlights the potential of molecular methods in surveillance for multidrug-resistant pathogens and in environmental sampling and the successful containment by application of specific control measures targeting biofilms within sink drains as potential environmental reservoirs for P aeruginosa.
High-risk clones harboring β-lactamases: 2024 update.
Flores-Vega V, Partida-Sanchez S, Ares M, Ortiz-Navarrete V, Rosales-Reyes R Heliyon. 2025; 11(1):e41540.
PMID: 39850428 PMC: 11754179. DOI: 10.1016/j.heliyon.2024.e41540.
Hanczvikkel A, Toth A, Kopcsone Nemeth I, Bazso O, Zavorszky L, Buzgo L Euro Surveill. 2024; 29(26).
PMID: 38940004 PMC: 11212457. DOI: 10.2807/1560-7917.ES.2024.29.26.2300492.
Gondal A, Choudhry N, Niaz A, Yasmin N Antibiotics (Basel). 2024; 13(2).
PMID: 38391577 PMC: 10886086. DOI: 10.3390/antibiotics13020191.
Pirzadian J, Voor In t Holt A, Hossain M, Klaassen C, de Goeij I, Koene H PLoS One. 2023; 18(3):e0282090.
PMID: 36961784 PMC: 10038242. DOI: 10.1371/journal.pone.0282090.
Diorio-Toth L, Irum S, Potter R, Wallace M, Arslan M, Munir T Microbiol Spectr. 2022; 10(3):e0076622.
PMID: 35638817 PMC: 9241860. DOI: 10.1128/spectrum.00766-22.